References
- Inoue T, Node K. Vascular failure: A new clinical entity for vascular disease. Journal of hypertension. 2006;24(11):2121-30. DOI: 10.1097/01.hjh.0000249684.76296.4f
- Ziaeian B, Fonarow G: Epidemiology and aetiology of heart failure. Nature Rev Cardiol. 2016;13(6):368-78. DOI: 10.1038/nrcardio.2016.25
- Narula J, Haider N, Arbustini E, Chandrashekhar Y. Mechanisms of disease: apoptosis in heart failure-seeing hope in death. Nature clinical practice Cardiovascular medicine 2006;3(12):681-8. DOI: 10.1038/ncpcardio0710
- Gaudino M, Andreotti F, Kimura T. Current concepts in coronary artery revascularisation. Lancet (London, England) 2023;401(10388):1611-28. DOI: 10.1016/S0140-6736(23)00459-2
- Agrawal R, Sharafkhaneh A, Nambi V, BaHammam A, Razjouyan J. Obstructive sleep apnea modulates clinical outcomes post-acute myocardial infarction: A large longitudinal veterans’ dataset report. Respiratory Med. 2023;211:107214. DOI: 10.1016/j. rmed.2023.107214
- Lu M, Fang F, Wang Z, Xu L, Sanderson J, Zhan X, et al. Association Between OSA and Quantitative Atherosclerotic Plaque Burden: A Coronary CT Angiography Study. Chest. 2021;160(5):1864-74. DOI: 10.1016/j.chest.2021.07.040
- Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. New England J Med. 2013;368(21):2004-2013. DOI: 10.1056/NEJMra1216063
- Björkegren J, Lusis A. Atherosclerosis: Recent developments. Cell. 2022;185(10):1630-45. DOI: 10.1016/j.cell.2022.04.004
- Daugherty A. Mouse models of atherosclerosis. Am J Med Sci. 2002;323(1):3-10. DOI: 10.1097/00000441-200201000-00002
- Zhang Y, Fatima M, Hou S, Bai L, Zhao S, Liu E. Research methods for animal models of atherosclerosis (Review). Molec Med Rep. 2021;24(6). DOI: 10.3892/mmr.2021.12511
- Morand J, Arnaud C, Pepin J, Godin-Ribuot D. Chronic intermittent hypoxia promotes myocardial ischemia-related ventricular arrhythmias and sudden cardiac death. Sci Rep. 2018;8(1):2997. DOI: 10.1038/s41598-018-21064-y
- [Chinese guidelines for the diagnosis and treatment of heart failure 2018]. Zhonghua xin xue guan bing za zhi 2018;46(10):760-89.
- Cowie M, Gallagher A. Sleep Disordered Breathing and Heart Failure: What Does the Future Hold? JACC Heart failure. 2017;5(10):715-23. DOI: 10.1016/j.jchf.2017.06.016
- Tsai H, Han M. Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation. Drugs. 2016;76(11):1067-79. DOI: 10.1007/s40265-016-0603-2
- Yu F, Yuan C, Tong J, Zhang G, Zhou F, Yang F. Protective effect of sphingosine-1-phosphate for chronic intermittent hypoxia-induced endothelial cell injury. Biochem Biophys Res Com. 2018;498(4):1016-21. DOI: 10.1016/j.bbrc.2018.03.106
- Maceyka M, Spiegel S: Sphingolipid metabolites in inflammatory disease. Nature. 2014;510(7503):58-67. DOI: 10.1038/nature13475
- Syed S, Raue R, Weigert A, von Knethen A, Brüne B. Macrophage S1PR1 Signaling Alters Angiogenesis and Lymphangiogenesis During Skin Inflammation. Cells. 2019;8(8). DOI: 10.3390/cells8080785
- Yoon C, Hong B, Moon H, Lim S, Suh P, Kim Y, et al. Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2+ signaling pathways. Blood. 2008;112(4):1129-1138. DOI: 10.1182/blood-2007-11-125203
- Zhang J, Hu C, Jiao X, Yang Y, Li J, Yu H, et al. Potential Role of mRNAs and LncRNAs in Chronic Intermittent Hypoxia Exposure-Aggravated Atherosclerosis. Front Genet. 2020;11:290. DOI: 10.3389/fgene.2020.00290
- Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC bioinformatics. 2008;9:559. DOI: 10.1186/1471-2105-9-559
- Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al: clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation. 2021;2(3):100141. DOI: 10.1016/j.xinn.2021.100141
- Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38(4):576-589. DOI: 10.1016/j. molcel.2010.05.004
- Zhang G, Yu F, Li Y, Wei Q, Song S, Zhou F, Tong J. Prolyl 4-Hydroxylase Domain Protein 3 Overexpression Improved Obstructive Sleep Apnea-Induced Cardiac Perivascular Fibrosis Partially by Suppressing Endothelial-to-Mesenchymal Transition. J Am Heart Assoc. 2017,;6(10). DOI: 10.1161/JAHA.117.006680
- Zhang J, Hu C, Jiao X, Yang Y, Li J, Yu H, et al. Potential Role of mRNAs and LncRNAs in Chronic Intermittent Hypoxia Exposure-Aggravated Atherosclerosis. Front Genetics. 2020;11:290. DOI: 10.3389/fgene.2020.00290
- Barile L, Lionetti V, Cervio E, Matteucci M, Gherghiceanu M, Popescu L, et al. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovascular Res. 2014, 103(4):530-541. DOI: 10.1093/cvr/cvu167
- Alioglu E, Ercan E, Sonmez Tamer G, Duman C, Turk U, Tengiz I, et al. Decreased circulatory erythropoietin in hyperacute phase of myocardial ischemia. Int J Cardiol. 2011;146(3):e49-52. DOI: 10.1016/j.ijcard.2008.12.184
- Bilo G, Gatterer H, Torlasco C, Villafuerte F, Parati G. Editorial: Hypoxia in cardiovascular disease. Front Cardiovasc Med. 2022;9:990013. DOI: 10.3389/fcvm.2022.990013
- Kubasiak L, Hernandez O, Bishopric N, Webster K. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proceedings of the National Academy of Sciences of the United States of America. 2002;99(20):12825-12830. DOI: 10.1073/pnas.202474099
- Pio-Abreu A, Moreno H, Drager L. Obstructive sleep apnea and ambulatory blood pressure monitoring: current evidence and research gaps. J Human Hypert. 2021;35(4):315-324. DOI: 10.1038/s41371-020-00470-8
- Cartier A, Hla T: Sphingosine 1-phosphate: Lipid signaling in pathology and therapy. Science 2019;366(6463). DOI: 10.1126/science.aar5551
- Bravo G, Cedeño R, Casadevall M, Ramió-Torrentà L. Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway Modulators, from Current Insights to Future Perspectives. Cells. 2022;11(13):2058. DOI: 10.3390/cells11132058
- Psallidas I, Stathopoulos G, Maniatis N, Magkouta S, Moschos C, Karabela S, et al. Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion. Oncogene. 2013;32(4):528-35. DOI: 10.1038/onc.2012.57
- Smith-Garvin JE, Koretzky GA, Jordan MS. T cell activation. Annu Rev Immunol. 2009;27:591-619. DOI: 10.1146/annurev. immunol.021908.132706
- Lee TS, Lu TM, Chen CH, Guo BC, Hsu CP. Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway. Redox Biol. 2021;46:102108. DOI: 10.1016/j.redox.2021.102108
- Mandl M, Kapeller B, Lieber R, Macfelda K. Hypoxia-inducible factor-1β (HIF-1β) is upregulated in a HIF-1α-dependent manner in 518A2 human melanoma cells under hypoxic conditions. Biochem Biophys Res Commun. 2013;434(1):166-72. DOI: 10.1016/j.bbrc.2013.03.051
- Semenza G: Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148(3):399-408. DOI: 10.1016/j.cell.2012.01.021
- Sato T, Takeda N. The roles of HIF-1α signaling in cardiovascular diseases. Journal of cardiology 2023.81(2):202-208. DOI: 10.1016/j.jjcc.2022.09.002
- Masoud G, Li W. HIF-1α pathway: role, regulation and intervention for cancer therapy. Acta Pharm Sin B. 2015 Sep;5(5):378-89. DOI: 10.1016/j.apsb.2015.05.007
- Sakai D, Sugawara T, Kurokawa T, Murakami Y, Tomosugi M, Masuta H, et al. Hif1α-dependent hypoxia signaling contributes to the survival of deep-layer neurons and cortex formation in a mouse model. Molec Brain. 2022;15(1):28. DOI: 10.1186/s13041-022-00911-0
- Bouquerel P, Gstalder C, Müller D, Laurent J, Brizuela L, Sabbadini RA, et al: Essential role for SphK1/S1P signaling to regulate hypoxia-inducible factor 2α expression and activity in cancer. Oncogenesis. 2016;5(3):e209. DOI: 10.1038/oncsis.2016.13
- Wu T, Shao Y, Li X, Wu T, Yu L, Liang J, et al. NR3C1/Glucocorticoid receptor activation promotes pancreatic β-cell autophagy overload in response to glucolipotoxicity. Autophagy. 2023:1-20. DOI: 10.1080/15548627.2023.2200625
- Sundahl N, Bridelance J, Libert C, De Bosscher K, Beck I. Selective glucocorticoid receptor modulation: New directions with nonsteroidal scaffolds. Pharmacol Therap. 2015;152:28-41. DOI: 10.1016/j.pharmthera.2015.05.001
- Leonard M, Godson C, Brady H, Taylor C. Potentiation of glucocorticoid activity in hypoxia through induction of the glucocorticoid receptor. J Immunol. 2005;174(4):2250-7. DOI: 10.4049/jimmunol.174.4.2250